Because not all cancer causing types of HPV are covered by the existing vaccines, women are still advised to undergo regular cervical screening for early detection of cervical abnormalities that could eventually lead to cancer.
WHO Europe is working with national health authorities to further develop and improve screening programmes and vaccination schemes. Improving accessibility, affordability and awareness are crucial to the success of these campaigns.
The Organization says preliminary data suggests that vaccine uptake is highest when delivered through a school-based programme and it continues to develop the evidence-base around the use of HPV vaccine.
Click here for more information on cervical cancer.
This article is part of a series compiled by Vaccines Today to raise awareness of European Immunization Week 2011 which runs from 23-30 April